Juan Serna

University of Pennsylvania, Mount Sinai Hospital

Papers

4

Total Citations

35

H-Index

2

About

Juan Serna is a urologic surgeon and researcher dedicated to transforming postoperative pain management and advancing minimally invasive surgical techniques. His primary research focuses on opioid stewardship in urologic oncology, particularly after robotic surgery. In his landmark PENN prospective cohort study, Serna demonstrated that the majority of robotic surgery patients require no opioids at discharge, implementing a standardized nonopioid protocol that dramatically reduced narcotic prescriptions while maintaining patient comfort. This work, cited over two dozen times, has helped reshape prescribing habits and combat the national opioid crisis. He has extended these principles to endourologic procedures, further reducing opioid use across the specialty. Serna is also at the forefront of single-port robotic surgery, contributing to novel approaches for penile cancer with robot-assisted superficial inguinal node dissection, a technically demanding procedure that minimizes morbidity. His contributions bridge quality improvement and surgical innovation, offering evidence-based, patient-centered solutions that reduce opioid exposure without compromising pain control. Through his research, Serna is helping to define a new standard of care in urologic oncology—one that prioritizes both recovery and public health.

Research Focus

Key Achievements

2
H-Index
4
Papers
35
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Preventing Excess Narcotic Prescriptions in New Robotic Surgery Discharges: The PENN Prospective Cohort Quality Improvement Initiative
24 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Pennsylvania, Mount Sinai Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago